Back to top

Syndax announces updated NCCN Guidelines for AML

Syndax (SNDX) Pharmaceuticals announced that the National Comprehensive Cancer Network, NCCN, Clinical Practice Guidelines in Oncology for Acute My...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Syndax Pharmaceuticals, Inc. (SNDX)